Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

Treatment of Yeast Infections During Pregnancy

First Trimester Treatment Options

  • The American College of Obstetricians and Gynecologists recommends topical azole antifungals, such as clotrimazole and miconazole, as first-line treatments for vulvovaginal candidiasis during the first trimester, due to their safety and effectiveness 1
  • Oral fluconazole and other systemic azole antifungals should be avoided during the first trimester due to potential teratogenic effects and risk of birth defects, with the FDA issuing warnings about high-dose fluconazole associated with birth defects including craniosynostosis, characteristic facies, digital synostosis, and limb contractures 1, 2
  • If systemic treatment is necessary during the first trimester, intravenous amphotericin B is recommended instead of oral azoles, as it is considered a safer alternative 3

Second and Third Trimester Treatment Options

  • After the first trimester, oral azole antifungals such as fluconazole or itraconazole may be considered with caution if topical therapy fails, according to current guidelines from the Infectious Diseases Society of America 1
  • Topical antifungal treatments remain the safest option throughout pregnancy, with a preference for azole-based therapies 1

Special Considerations

  • Alternative treatments such as honey-based ointments, essential oils, and herbal remedies are generally not recommended for treating vulvovaginal candidiasis during pregnancy, as they are often equal or inferior to prescribed medications and lack regulatory approval 1
  • The Centers for Disease Control and Prevention suggest that treatment of sexual partners is generally not necessary unless they are also symptomatic 4
  • Failure to recognize that vulvovaginal candidiasis may be associated with increased risk of preterm delivery is a common pitfall, though more high-quality studies are needed to further investigate this relationship 1

Treatment of Yeast Infections in Pregnancy

First-Line Treatment Regimen

  • The Centers for Disease Control and Prevention recommends Clotrimazole 1% cream 5g intravaginally for 7-14 days for the treatment of vulvovaginal candidiasis in pregnant women 5
  • The Centers for Disease Control and Prevention recommends Miconazole 2% cream 5g intravaginally for 7 days for the treatment of vulvovaginal candidiasis in pregnant women 5
  • The Centers for Disease Control and Prevention recommends Butoconazole 2% cream 5g intravaginally for 3 days for the treatment of vulvovaginal candidiasis in pregnant women 5
  • The Centers for Disease Control and Prevention recommends Terconazole 0.4% cream 5g intravaginally for 7 days for the treatment of vulvovaginal candidiasis in pregnant women 5

Clinical Diagnosis Confirmation

  • Diagnosis of vulvovaginal candidiasis should be confirmed by wet preparation or Gram stain demonstrating yeasts or pseudohyphae, or culture yielding a positive result for a yeast species, according to the Centers for Disease Control and Prevention 5
  • The vaginal pH should be ≤4.5 in isolated Candida vaginitis, as recommended by the Centers for Disease Control and Prevention 5
  • Identifying Candida in asymptomatic women should not prompt treatment, as stated by the Centers for Disease Control and Prevention 5